申请人:Takeda Pharmaceutical Company Limited
公开号:US10005780B2
公开(公告)日:2018-06-26
The present invention provides an advantageous production method of an imidazole derivative, which is suitable for industrial production. Compound (VI) is produced by reacting compound (I) with a Grignard reagent or a magnesium reagent, and a lithium reagent, and then reacting the resulting compound with compound (V).
本发明提供了一种适用于工业生产的咪唑衍生物的有利生产方法。化合物(VI)是通过化合物(I)与格氏试剂或镁试剂和锂试剂反应,然后将生成的化合物与化合物(V)反应制得的。